Solid dispersion composition of levocarnitine as well as preparation method and medical application of solid dispersion composition
A technology of solid dispersion and composition, which is applied in the directions of non-active ingredients of polymer compounds, drug delivery, medical preparations containing active ingredients, etc. Problems such as preparation, storage, and adverse effects of circulation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0065] Embodiment 1, the granule of the solid dispersion of levocarnitine or its tartrate and sugar alcohol substance and preparation thereof
[0066] The prescription quantity is calculated by weight percentage and contains:
[0067] Levocarnitine or its tartrate 2% to 10%, preferably 3% of levocarnitine tartrate,
[0068] Polydextrose 25%~55%, preferably 38%,
[0069] Fructose or xylitol 45% to 65%, preferably 59% fructose;
[0070] Its preparation method includes: passing polydextrose, fructose or xylitol through 80 mesh sieves, preferably 100 meshes, weighing according to the prescription amount, mixing evenly, and dissolving levocarnitine or its tartrate in 75% ethanol Solution, the solution is evenly sprayed in the mixture of polydextrose and fructose or xylitol to make a soft material, wet granulated, dried at 45-70°C, granulated, bagged, sealed, and ready to be obtained;
[0071] Alternatively, the preparation method includes: taking levocarnitine or its tartrate, p...
Embodiment 2
[0077] Embodiment 2, the granule of the solid dispersion of levocarnitine or its tartrate and sugar alcohol substance and its preparation
[0078] The prescription quantity is calculated by weight percentage and contains:
[0079] Levocarnitine or its tartrate 2% to 10%, preferably 5% of levocarnitine tartrate,
[0080] fructooligosaccharide 25%~55%, preferably 30%,
[0081] Resistant dextrin 50% to 75%, preferably 65%;
[0082] Its preparation method includes: passing the fructooligosaccharide and resistant dextrin through 80-mesh sieve, preferably 100-mesh sieve, weighing according to the prescription amount, mixing evenly, and dissolving levocarnitine or its tartrate in 75% ethanol Solution, the solution is evenly sprayed in the mixture of fructooligosaccharide and resistant dextrin to make a soft material, wet granulated, dried at 45-70°C, granulated, bagged, sealed, and obtained;
[0083] Alternatively, the preparation method comprises: taking levocarnitine or its tart...
Embodiment 3
[0089] Embodiment 3, the granule of the solid dispersion of levocarnitine or its tartrate and sugar alcohol substance and its preparation
[0090] The prescription quantity is calculated by weight percentage and contains:
[0091] Levocarnitine or its tartrate 5% to 15%, preferably 10% of levocarnitine tartrate,
[0092] Mannose oligosaccharide 5%~10%, preferably 7.5%,
[0093] Sorbitol 50%~75%, preferably 65%;
[0094] The preparation method comprises: passing oligomannose and sorbitol through 80-mesh sieve, preferably 100-mesh sieve, weighing according to the prescription amount, mixing evenly, and dissolving levocarnitine or its tartrate in 75% ethanol Solution, the solution is uniformly sprayed in the mixture of mannose oligosaccharide and sorbitol to make a soft material, wet granulated, dried at 45-70°C, sized, bagged, sealed, and ready to be obtained;
[0095] Alternatively, the preparation method comprises: taking levocarnitine or its tartrate, mannose oligosacchari...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com